Free Trial
NASDAQ:QLGN

Qualigen Therapeutics (QLGN) Stock Price, News & Analysis

Qualigen Therapeutics logo
$3.65 -0.12 (-3.18%)
Closing price 03:59 PM Eastern
Extended Trading
$3.61 -0.04 (-1.10%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Qualigen Therapeutics Stock (NASDAQ:QLGN)

Key Stats

Today's Range
$3.65
$3.82
50-Day Range
$3.00
$3.94
52-Week Range
$2.85
$29.44
Volume
5,494 shs
Average Volume
113,291 shs
Market Capitalization
$2.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Receive QLGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

QLGN Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
See More Headlines

QLGN Stock Analysis - Frequently Asked Questions

Qualigen Therapeutics' stock was trading at $4.21 on January 1st, 2025. Since then, QLGN shares have decreased by 13.3% and is now trading at $3.65.
View the best growth stocks for 2025 here
.

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) issued its quarterly earnings results on Tuesday, August, 15th. The company reported ($34.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($26.00) by $8.50. The company earned $1.63 million during the quarter, compared to analyst estimates of $1.60 million.

Shares of Qualigen Therapeutics reverse split before market open on Tuesday, November 5th 2024. The 1-50 reverse split was announced on Friday, November 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Qualigen Therapeutics' top institutional shareholders include FNY Investment Advisers LLC (1.03%). Insiders that own company stock include Michael S Poirier and Amy S Broidrick.
View institutional ownership trends
.

Shares of QLGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qualigen Therapeutics investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), Bank of America (BAC), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
8/15/2023
Today
5/27/2025
Next Earnings (Estimated)
7/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QLGN
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,420,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.98 million
Price / Cash Flow
N/A
Book Value
($20.31) per share
Price / Book
-0.19

Miscellaneous

Free Float
723,000
Market Cap
$2.77 million
Optionable
Not Optionable
Beta
-0.07
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:QLGN) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners